Sign up to our newsletter

Stay up-to-date with the latest news, events and more

Area(s) of Interest *

Please tick all that apply so that we can better assist you!

Logo
BioGene
  • Strategy
    AT PATIENT TESTING® One Health Approach
  • CENOS PLATFORM
    • CENOS Analyser
    • XF Reagent System
    • Human Assays
    • Veterinary Assays
      • Avian Influenza Virus
      • African Swine Fever Virus
      • Foot and Mouth Disease Virus
      • Newcastle Disease Virus
      • Seneca Valley Virus
    • ASSAY DEVELOPMENT & VALIDATION PIPELINE
  • Solutions
    Pandemic PreparednessIn-Field Mobile TestingCentralised HealthcareVeterinaryZoonoticMilitary & DefenceBiosecurity
  • The Molecular Edge
  • About Us
    Our VisionQuality AssuranceCareers
  • Support
    Contact Us
← Back to Media Centre

Ebola

Direct-from-blood Molecular Testing
4 min read 31st March 2026
Article Ebola

Direct-from-blood Molecular Testing

Why it matters for One Health, outbreak control, and real-time decisions. Blood is the clinically critical matrix for several high-consequence infections because viraemia or systemic spread appears early, while the decision window stays short. That is true in both human and animal health. Whole blood is a priority specimen for Ebola testing, and EDTA-blood is a recommended sample for early ASFV PCR detection.

BioGene logo

6 The Business Centre, Harvard Way, Kimbolton, Huntingdon, PE28 0NJ

Need Help?

+44 (0) 3333 222 678

[email protected]

Connect with BioGene
Sign up to our newsletter

ISO 13485

© 2026 Copyright BioGene Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions